Kieseier, Bernd C.
Mathey, Emily K.
Sommer, Claudia
Hartung, Hans-Peter
Article History
First Online: 11 October 2018
Competing interests
: B.C.K. reports receiving personal fees for consulting for Grifols and UCB. E.K.M. reports receiving funding from the GBS/CIDP Foundation International and the National Health and Medical Research Council of Australia and is a member of the Scientific Committee of the Trish Multiple Sclerosis Research Foundation. C.S. reports receiving personal fees for educational talks for Alnylam, CSL Behring, Grifols, Kedrion, Sanofi-Genzyme, Shire and Pfizer; personal fees for consulting for Air Liquide, Alnylam, Astellas, Baxalta and UCB; and research support to the institution from Kedrion. H.-P.H. reports CSL Behring fees for serving on a steering committee and from UCB for participating on advisory boards.